Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems - PubMed (original) (raw)

Review

Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems

Ivano Amelio et al. Oncotarget. 2015.

Abstract

Targeting the ubiquitin-proteasome system (UPS) and ubiquitin-like signalling systems (UBL) has been considered a promising therapeutic strategy to treat cancer, neurodegenerative and immunological disorders. There have been multiple efforts recently to identify novel compounds that efficiently modulate the activities of different disease-specific components of the UPS-UBL. However, it is evident that polypharmacology (the ability to affect multiple independent protein targets) is a basic property of small molecules and even highly potent molecules would have a number of "off target" effects. Here we have explored publicly available high-throughput screening data covering a wide spectrum of currently accepted drug targets in order to understand polypharmacology of small molecules targeting different components of the UPS-UBL. We have demonstrated that molecules targeting a given UPS-UBL protein also have high odds to target a given off target spectrum. Moreover, the off target spectrum differs significantly between different components of UPS-UBL. This information can be utilized further in drug discovery efforts, to improve drug efficiency and to reduce the risk of potential side effects of the prospective drugs designed to target specific UPS-UBL components.

Keywords: SUMO; UBC13; UBL; UCH37; UPS.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

There is no conflict of interest.

Similar articles

Cited by

References

    1. Welchman RL, Gordon C, Mayer RJ. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nature reviews Molecular cell biology. 2005;6:599–609. - PubMed
    1. Blagosklonny MV, Wu GS, Omura S, ElDeiry WS. Proteasome-dependent regulation of p21(WAF1/CIP1) expression. Biochemical and biophysical research communications. 1996;227:564–569. - PubMed
    1. Blagosklonny MV. Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors. Oncogene. 2001;20:395–398. - PubMed
    1. Hershko A, Heller H, Elias S, Ciechanover A. Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. The Journal of biological chemistry. 1983;258:8206–8214. - PubMed
    1. Thrower JS, Hoffman L, Rechsteiner M, Pickart CM. Recognition of the polyubiquitin proteolytic signal. The EMBO journal. 2000;19:94–102. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources